tiprankstipranks
Trending News
More News >
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market
Advertisement

Allergy Therapeutics (AGY) Share Forecast & Price Target

Compare
16 Followers
See the Price Targets and Ratings of:

AGY Financial Forecast

AGY Earnings Forecast

The previous quarter’s earnings for AGY were >-0.01p.
The previous quarter’s earnings for AGY were >-0.01p.

AGY Sales Forecast

Next quarter’s sales forecast for AGY is 23.97M with a range of 23.97M to 23.97M. The previous quarter’s sales results were 34.03M. AGY beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.38% of the time in the same period. In the last calendar year AGY has Preformed in-line its overall industry.
Next quarter’s sales forecast for AGY is 23.97M with a range of 23.97M to 23.97M. The previous quarter’s sales results were 34.03M. AGY beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.38% of the time in the same period. In the last calendar year AGY has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on GB:AGY
TipRanks AITipRanks
Not Ranked
TipRanks
8p
Hold
-1.23%
Downside
Reiterated
07/01/25
Allergy Therapeutics has significant financial challenges, which are the most impactful factor on its stock score. However, technical analysis shows some positive momentum, and promising corporate events suggest potential future growth, partially offsetting financial weaknesses. Valuation concerns remain due to negative earnings.
AI Firm
6.5p7.5p
Hold
-7.41%
Downside
Reiterated
06/14/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on GB:AGY
TipRanks AITipRanks
Not Ranked
TipRanks
8p
Hold
-1.23%
Downside
Reiterated
07/01/25
Allergy Therapeutics has significant financial challenges, which are the most impactful factor on its stock score. However, technical analysis shows some positive momentum, and promising corporate events suggest potential future growth, partially offsetting financial weaknesses. Valuation concerns remain due to negative earnings.
AI Firm
6.5p7.5p
Hold
-7.41%
Downside
Reiterated
06/14/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AGY Analyst Recommendation Trends

Rating
Jul 22
Oct 22
Nov 22
Jun 25
Jul 25
Strong Buy
3
3
3
2
1
Buy
0
0
0
0
0
Hold
0
0
0
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
5
6
In the current month, AGY has received 1 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. AGY average Analyst price target in the past 3 months is 7.50.
Each month's total comprises the sum of three months' worth of ratings.

AGY Stock Forecast FAQ

What is GB:AGY’s average 12-month price target, according to analysts?
Based on analyst ratings, Allergy Therapeutics PLC’s 12-month average price target is 7.50.
    What is GB:AGY’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for GB:AGY, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Allergy Therapeutics PLC a Buy, Sell or Hold?
        Allergy Therapeutics PLC has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Allergy Therapeutics PLC’s share price target?
          The average share price target for Allergy Therapeutics PLC is 7.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is 7.50p ,and the lowest forecast is 7.50p. The average share price target represents -7.41% Decrease from the current price of 8.1p.
            What do analysts say about Allergy Therapeutics PLC?
            Allergy Therapeutics PLC’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of Allergy Therapeutics PLC?
              To buy shares of GB:AGY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis